Adial Pharmaceuticals Inc – Filings and Transcripts

NASDAQ: ADIL
Share price (3/13/26): $1.96
Market cap (3/13/26): $2.799 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Exempt offering of securities

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Armistice Capital, LLC

Intracoastal Capital, LLC

Gilliland Robertson H.

Newman James W. Jr.

News Filter

Reports 2025 Fiscal Year Financial Results and Provides Business Update

Signs an Exclusive AD04 Collaboration Framework With Molteni Farmaceutici for Europe Which Anticipates Nearly $60 Million in Potential Royalties and Milestones Upon Execution of a Definitive Agreement

Regains Full Compliance With Nasdaq Listing Requirement

Announces Reverse Stock Split to Regain Compliance With Nasdaq’s Minimum Bid Price Requirement

Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Preliminary proxy

Preliminary revised proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Scanned paper annual report submission